Improvements in proximal aortic stiffness greater with combo of exercise, moderate CR versus exercise alone or with intensive CR
ADA: Tirzepatide non-inferior, superior to Semaglutide for T2DM
Jun 29, 2021
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
Time to turn off the TV? Nighttime exposure to artificial light tied to obesity in women
By
Alicia Lasek
Jun 10, 2019
Older women who leave the television and other lights on while asleep have a higher likelihood of becoming obese, according to a study published in JAMA Internal Medicine.
Caring for the bariatric resident
By
Karen Lerner
May 16, 2018
Navigating the tumultuous road of caring for bariatric residents is a challenge faced by many long-term care facilities today. Using the right equipment or technology on the right type of patient will...
Also in the News for Monday, April 9
Apr 09, 2018
Post-acute providers should provide targeted care for obese hip-fracture patients … LeadingAge, American Health Care Association seek compensation data for partner’s annual nursing home salaries...
Maker of SimSleeves acquired
Sep 07, 2016
Pocket Nurse® will acquire Eriter Creations Inc., manufacturers of SimLeggings™, SimSleeves™, and SimObesity™ products for simulation.
Diabetes growth to drive wound market
By
Elizabeth Newman
Nov 01, 2014
A rise in diabetes and obesity will drive the increase in the wound care market over the next four years, a research group asserts.
FDA approves weight management drug
Sep 16, 2014
The U.S. Food and Drug Administration has approved Contrave as a treatment for chronic weight management. Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, in an extended-release...